Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OTSTQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ASAC-02
|
|||||
| Synonyms |
ASAC-02
Click to Show/Hide
|
|||||
| Organization |
Beijing Institute of Pharmacology and Toxicology; Nanjing Medical University; Nanjing University of Chinese Medicine; Chinese Academy of Medical Sciences and Peking Union Medical College; Jiangsu Province Academy of Traditional Chinese Medicine.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.79
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
KRM-1657
|
Payload Info | ||||
| Linker Name |
M6 Linker
|
Linker Info | ||||
| Conjugate Type |
Site-specific antibody conjugation using modified bisected N-Glycans.
|
|||||